Govt’s AEFI Panel to Review Covishield Vaccine Side Effects
AstraZeneca's Covishield and Bharat Biotech International's Covaxin have come under serious scrutiny,…
Junshi Biosciences, AstraZeneca Partner To Commercialise Toripalimab In China
Biopharmaceutical company Junshi Biosciences has entered into an exclusive promotion agreement with…
AstraZeneca’s Dapagliflozin Approves In India For Treatment Of Patients With Heart Failure
Dapagliflozin (Forxiga) is the first SGLT-2 inhibitor proven to significantly reduce the…
